​

Verrica Pharmaceuticals (VRCA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Verrica Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$35.58M

Latest Revenue (Q)

$5.02M

Main Segment (Y)

License And Collaboration Revenue

Verrica Pharmaceuticals Revenue by Period

Verrica Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$35.58M370.22%
2024-12-31$7.57M47.66%
2023-12-31$5.12M-43.27%
2022-12-31$9.03M-24.73%
2021-12-31$12.00M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Verrica Pharmaceuticals generated $35.58M in revenue during NA 2025, up 370.22% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue by Quarter

DateRevenueChange
2026-03-31$5.02M-1.36%
2025-12-31$5.09M-64.50%
2025-09-30$14.34M12.93%
2025-06-30$12.70M269.35%
2025-03-31$3.44M899.71%
2024-12-31$344.00K-119.31%
2024-09-30$-1.78M-134.40%
2024-06-30$5.18M35.31%
2024-03-31$3.83M92.45%
2023-12-31$1.99M-31.85%
2023-09-30$2.92M1502.75%
2023-06-30$182.00K391.89%
2023-03-31$37.00K-45.59%
2022-12-31$68.00K-99.18%
2022-09-30$8.32M3787.38%
2022-06-30$214.00K-50.35%
2022-03-31$431.00K100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$12.00M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Verrica Pharmaceuticals generated $5.02M in revenue during Q1 2026, up -1.36% compared to the previous quarter, and up 1460.17% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue Breakdown

Verrica Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23
License And Collaboration Revenue$20.29M--
Product$15.29M$6.57M$4.66M
Collaboration-$992.00K$466.00K

Verrica Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: License And Collaboration Revenue (57.04%), and Product (42.96%).

Quarterly Revenue by Product

Product/ServiceMar 26Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24
License And Collaboration Revenue$733.00K$10.74M$8.17M-----
Product$4.29M$3.61M$4.53M$3.42M$315.00K$-1.86M$4.89M$3.23M
Collaboration---$17.00K$29.00K$84.00K$285.00K$594.00K

Verrica Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Product (85.41%), and License And Collaboration Revenue (14.59%).

Verrica Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VRCAVerrica Pharmaceuticals$35.58M$5.02M
GBIOGeneration Bio$19.89M$765.00K
EVAXEvaxion Biotech$73.11K$50.88K
ANTXAN2 Therapeutics--
SABSSAB Biotherapeutics--
BOLDBoundless Bio--
NXTCNextCure--
MURAMural Oncology--
QTTBQ32 Bio--
JSPRJasper Therapeutics--
PSTVPlus Therapeutics-$1.03M

VRCA Revenue FAQ

What is Verrica Pharmaceuticals’s yearly revenue?

Verrica Pharmaceuticals's yearly revenue for 2025 was $35.58M, representing an increase of 370.22% compared to 2024. The company's yearly revenue for 2024 was $7.57M, representing an increase of 47.66% compared to 2023. VRCA's yearly revenue for 2023 was $5.12M, representing a decrease of -43.27% compared to 2022.

What is Verrica Pharmaceuticals’s quarterly revenue?

Verrica Pharmaceuticals's quarterly revenue for Q1 2026 was $5.02M, a -1.36% decrease from the previous quarter (Q4 2025), and a 46.06% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $5.09M, a -64.50% decrease from the previous quarter (Q3 2025), and a 1380.23% increase year-over-year (Q4 2024). VRCA's quarterly revenue for Q3 2025 was $14.34M, a 12.93% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Verrica Pharmaceuticals’s revenue growth rate?

Verrica Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 594.32%, and for the last 5 years (2021-2025) was 196.47%.

What are Verrica Pharmaceuticals’s revenue streams?

Verrica Pharmaceuticals's revenue streams in c 25 are License And Collaboration Revenue, and Product. License And Collaboration Revenue generated $20.29M in revenue, accounting 57.04% of the company's total revenue Product generated $15.28M in revenue, accounting 42.96% of the company's total revenue, up 132.51% year-over-year.

What is Verrica Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Verrica Pharmaceuticals was License And Collaboration Revenue. This segment made a revenue of $20.29M, representing 57.04% of the company's total revenue.